可解释联合模型预测局部晚期胃癌PD-1阻断联合新辅助化疗的治疗反应与血液学毒性
本研究基于两个中心195例局部晚期胃癌患者,从治疗前后胃部CT提取影像组学特征变化构建delta影像组学评分预测治疗反应,并从治疗前椎体CT提取影像组学评分预测血液学毒性,联合临床病理特征建立联合模型。联合模型预测治疗反应的AUC在训练、内部验证和外部验证队列分别为0.893、0.846和0.913,预测血液学毒性的AUC分别为0.871、0.917和0.865,SHAP框架用于评估可解释性。
要点
- 基于治疗前后胃部CT的delta影像组学评分联合临床病理特征预测治疗反应,外部验证AUC为0.913。
- 基于治疗前椎体CT的影像组学评分联合临床病理特征预测血液学毒性,外部验证AUC为0.865。
- SHAP汇总图显示各特征对预测结局的重要性,瀑布图和力图表展示个体特征对反应变量的贡献。
核心结论
- 基于影像组学特征的联合模型预测局部晚期胃癌PD-1阻断联合新辅助化疗后的治疗反应和血液学毒性表现出良好的预测性能。
研究设计与样本
- 回顾性纳入两个中心共195例局部晚期胃癌患者,训练队列117例、内部验证队列50例、外部验证队列28例;从治疗前后胃部CT图像提取影像组学特征变化构建delta影像组学评分预测治疗反应,从治疗前椎体CT图像提取影像组学评分预测血液学毒性,联合临床病理特征和影像组学评分建立两个联合模型,采用受试者工作特征曲线、校准曲线和决策曲线分析评估预测性能,采用SHAP框架评估可解释性。
诊断标准与关键数值
- 预测治疗反应的联合模型AUC:训练队列0.893,内部验证队列0.846,外部验证队列0.913。
- 预测血液学毒性的联合模型AUC:训练队列0.871,内部验证队列0.917,外部验证队列0.865。
临床应用与阅片要点
- SHAP汇总图可展示各特征对预测结局的重要性,瀑布图和力图表可展示个体特征对反应变量的贡献。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to establish and validate the interpretable combined models for treatment response (TR) and hematologic toxicity (HT) after programmed cell death protein 1 blockade plus neoadjuvant chemotherapy in locally advanced gastric cancer (LAGC).
METHODS: 195 patients with LAGC were enrolled from two centres (117, 50 and 28 patients in the training, internal validation and external validation cohorts). The changes of radiomics features from pre-treatment and post-treatment gastric computed tomography images were extracted to build delta radiomics score and predict TR, as well as another radiomics score from pre-treatment vertebral computed tomography images for the prediction of HT, and both combined models were established from clinicopathological characteristics and radiomics score. The predictive performance of the combined models were evaluated using receiver operating characteristics, calibration and decision curve analyses. Interpretability was assessed using the shapley additive explanations framework (SHAP).
RESULTS: The area under curve (AUC) in the combined model for predicting TR were 0.893,0.846 and 0.913 for the training, internal validation and external validation cohorts, respectively. The AUC in the combined model for predicting HT were 0.871, 0.917 and 0.865 for the training, internal validation and external validation cohorts, respectively. SHAP summary plots show the importance of each feature on the prediction outcome, while waterfall and force plots depict individual features' contributions to a response variable.
CONCLUSIONS: The combined models based on radiomics features for predicting TR and HT after programmed cell death protein 1 blockade plus neoadjuvant chemotherapy in LAGC demonstrated good predictive performance.
引用
- Wei Y, Zhu Y, Dong Q, et al. Interpretable combined models for predicting treatment response and hematologic toxicity in locally advanced gastric cancer treated with PD-1 blockade and neoadjuvant chemotherapy. Eur J Radiol. 2025. PMID: 40543283. doi:10.1016/j.ejrad.2025.112256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。